Contact this trialFirst, we need to learn more about you.
RNA-based Therapy
ALN-APP for Cerebral Amyloid Angiopathy
Recruiting0 awardsPhase 2
New York, New York
This trial aims to test how well ALN-APP works in slowing down the progression of CAA disease in adults with sCAA and D-CAA. The study will include a 24-month period
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service